Chronic beryllium disease: T cell recognition of a metal presented by HLA-DP.
Fontenot
A P
AP
Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA.
Newman
L S
LS
Kotzin
B L
BL
D000595:Amino Acid Sequence; D000818:Animals; D017951:Antigen Presentation / Q000276:immunology*; D001607:Berylliosis / Q000235:genetics / Q000276:immunology*; D001608:Beryllium / Q000009:adverse effects / Q000276:immunology*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D002516:Ceramics; D004285:Dogs; D005544:Forecasting; D020022:Genetic Predisposition to Disease; D006682:HLA-DP Antigens / Q000235:genetics / Q000276:immunology*; D059868:HLA-DP beta-Chains; D006684:HLA-DR Antigens / Q000235:genetics / Q000276:immunology; D059811:HLA-DRB1 Chains; D006801:Humans; D008213:Lymphocyte Activation; D051379:Mice; D008805:Mice, Inbred A; D008809:Mice, Inbred C3H; D023421:Models, Animal; D008958:Models, Molecular; D008969:Molecular Sequence Data; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000276:immunology; D016415:Sequence Alignment; D017386:Sequence Homology, Amino Acid
D006682:HLA-DP Antigens; D059868:HLA-DP beta-Chains; C071170:HLA-DPB1 antigen; D006684:HLA-DR Antigens; D059811:HLA-DRB1 Chains; D016693:Receptors, Antigen, T-Cell, alpha-beta; C020711:beryllium sulfate; C032777:beryllium oxide; D001608:Beryllium